Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:09
David Joplin’s last lap at Marquette
-
3:01
Natalie’s Everyday Heroes: Leslie Scott creates special events...
-
0:48
Special Olympics athletes shoot hoops with former Bucks player...
-
0:56
Young essay contest winners recognized during MLK Jr. Day celebration...
-
0:42
Milwaukee’s Jewish community gathers for prayer to mark ceasefire,...
-
2:11
How to keep your pets and vehicles safe in extreme cold
-
0:57
Whitefish Bay church helps give back to community members in...
-
1:38
Wisconsin’s congressional delegation reacts to Trump inauguration
-
1:40
Milwaukeeans celebrate Dr. Martin Luther King Jr. Day with call...
-
2:45
How President Trump’s immigration executive order could affect...
-
1:16
Where to stay warm in Milwaukee amid the extreme cold weather...
-
2:05
Wisconsin congressman says act of arson at his office over TikTok...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.